Twitch streamer Jynxzi says he plans to “grind” Counter-Strike 2 after trying the game for the first time on stream.

Astralis dominates 3DMAX with a 2-0 sweep to secure a spot in Stage 2 of ESL Pro League Season 23. Read the full match breakdown of Dust2 and Overpass here.

Player count affects value too. 1v1 battles offer 50% win probability before commission. Adding opponents reduces individual win chances but increases prize pool size. A four-player battle gives 25% ...

The Audeze Maxwell 2 is a technically brilliant headset, making it ideal for competitive shooters and immersive single-player games. That said, its hefty weight, fiddly adjustment system, and cramped ...

Digital item trading has become a business for many players. When you are interested in smartly trading CS2 skins, it is important to select the appropriate marketplace. Your ultimate profit can vary ...

The DS has been overthrown, 12 years after it was discontinued. The DS has been overthrown, 12 years after it was discontinued. is a news writer focused on creative industries, computing, and ...

Check out this big price drop on a lightweight gaming mouse with no lack of flair. Starting today, Amazon has dropped the price of the SteelSeries Counter-Strike 2 Dragon Lore Limited Edition wireless ...

Can Counter-Strike’s legacy still perform against the newest engines and builds? Unlike past challengers, the Fortnite Ballistic game isn’t trying to replace CS2 by imitation; it is its own game, ...

As one analyst predicts that the Nintendo Switch 2 will see a price increase this year, another analyst suggests that the Mario maker's Switch successor may not maintain the same sales figures as its ...

James Ratcliff joined GameRant in 2022 as a Gaming News Writer. In 2023, James was offered a chance to become an occasional feature writer for different games and then a Senior Author in 2025. He is a ...

Thirty million Americans have a rare disease. Two-thirds of those 30 million are children. There are more than 10,000 rare diseases – 95% of which don’t have an FDA-approved treatment. But despite ...

Becky Quick outlines her daughter's personal struggle with SYNGAP1. Quick explains why her daughter's journey inspired her to launch CNBC Cures. I've spent the last 25 years in front of the camera ...